Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J6RQ
|
||||
Former ID |
DNC008724
|
||||
Drug Name |
1,5-bis(4-hydroxyphenyl)penta-1,4-dien-3-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C17H14O3
|
||||
Canonical SMILES |
C1=CC(=CC=C1C=CC(=O)C=CC2=CC=C(C=C2)O)O
|
||||
InChI |
1S/C17H14O3/c18-15-7-1-13(2-8-15)5-11-17(20)12-6-14-3-9-16(19)10-4-14/h1-12,18-19H/b11-5+,12-6+
|
||||
InChIKey |
FTEGUKWEUQPKIS-YDWXAUTNSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 2D6 | Target Info | Inhibitor | [1] | |
KEGG Pathway | Metabolism of xenobiotics by cytochrome P450 | ||||
Drug metabolism - cytochrome P450 | |||||
Serotonergic synapse | |||||
Reactome | Xenobiotics | ||||
WikiPathways | Metapathway biotransformation | ||||
Tamoxifen metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Vitamin D Receptor Pathway | |||||
Aripiprazole Metabolic Pathway | |||||
Fatty Acid Omega Oxidation | |||||
Codeine and Morphine Metabolism | |||||
References | |||||
REF 1 | Eur J Med Chem. 2008 Aug;43(8):1621-31. Epub 2007 Nov 17.Structure-activity relationships for the inhibition of recombinant human cytochromes P450 by curcumin analogues. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.